Billing and Coding: MolDX: Breast Cancer Index (BCI) Gene Expression Test - R14 - Effective October 09, 2021

This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Effective Date: October 09, 2021
Summary of Article Changes:
Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted C50.911 and C50.912. Under article text added the information in this article contains billing, coding, or other guidelines that complement the Local Coverage Determination (LCD) for MolDX: Breast Cancer Index® (BCI) Gene Expression Test.

Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.

To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.

            Last Updated Mon, 27 Dec 2021 16:56:10 +0000